{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:00:07Z","timestamp":1787238007238,"version":"build-2736575974"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,29]]},"DOI":"10.7759\/cureus.102557","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:34:17Z","timestamp":1769697257000},"source":"Crossref","is-referenced-by-count":1,"title":["Neuro-Ophthalmic Presentation of Steroid 5a-Reductase Type 3 Congenital Disorder of Glycosylation: A Case of Monozygotic Twins"],"prefix":"10.7759","author":[{"given":"Shikha","family":"Swaroop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeshna","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikhar Deep","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deb Sanjay","family":"Nag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K","family":"Tanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2018.10.45","article-title":"Congenital disorders of glycosylation","volume":"6","author":"Chang IJ","year":"2018","unstructured":"Chang IJ, He M, Lam CT. Congenital disorders of glycosylation. Ann Transl Med. 2018, 6:477. 10.21037\/atm.2018.10.45","journal-title":"Ann Transl Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.06.001","article-title":"SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder","volume":"142","author":"Cantagrel V","year":"2010","unstructured":"Cantagrel V, Lefeber DJ, Ng BG, et al.. SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell. 2010, 142:203-17. 10.1016\/j.cell.2010.06.001","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-020-0647-3","article-title":"SRD5A3 defective congenital disorder of glycosylation: clinical utility gene card","volume":"28","author":"Jaeken J","year":"2020","unstructured":"Jaeken J, Lefeber DJ, Matthijs G. SRD5A3 defective congenital disorder of glycosylation: clinical utility gene card. Eur J Hum Genet. 2020, 28:1297-300. 10.1038\/s41431-020-0647-3","journal-title":"Eur J Hum Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.37875","article-title":"SRD5A3-CDG: expanding the phenotype of a congenital disorder of glycosylation with emphasis on adult onset features","volume":"170","author":"Wheeler PG","year":"2016","unstructured":"Wheeler PG, Ng BG, Sanford L, et al.. SRD5A3-CDG: expanding the phenotype of a congenital disorder of glycosylation with emphasis on adult onset features. Am J Med Genet A. 2016, 170:3165-71. 10.1002\/ajmg.a.37875","journal-title":"Am J Med Genet A"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1590\/2326-4594-jiems-2022-0010","article-title":"Characterization of the SRD5A3-CDG clinical spectrum","volume":"11","author":"Daescu V","year":"2023","unstructured":"Daescu V, Goodspeed K, Horton D. Characterization of the SRD5A3-CDG clinical spectrum. J Inborn Errors Metab Screen. 2023, 11:e20220010. 10.1590\/2326-4594-jiems-2022-0010","journal-title":"J Inborn Errors Metab Screen"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.0046","article-title":"Association of steroid 5\u03b1-reductase type 3 congenital disorder of glycosylation with early-onset retinal dystrophy","volume":"135","author":"Taylor RL","year":"2017","unstructured":"Taylor RL, Arno G, Poulter JA, et al.. Association of steroid 5\u03b1-reductase type 3 congenital disorder of glycosylation with early-onset retinal dystrophy. JAMA Ophthalmol. 2017, 135:339-47. 10.1001\/jamaophthalmol.2017.0046","journal-title":"JAMA Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_820_16","article-title":"Identification of a case of SRD5A3-congenital disorder of glycosylation (CDG1Q) by exome sequencing","volume":"147","author":"Gupta N","year":"2018","unstructured":"Gupta N, Verma G, Kabra M, Bijarnia-Mahay S, Ganapathy A. Identification of a case of SRD5A3-congenital disorder of glycosylation (CDG1Q) by exome sequencing. Indian J Med Res. 2018, 147:422-6. 10.4103\/ijmr.IJMR_820_16","journal-title":"Indian J Med Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.737094","article-title":"SRD5A3-CDG: emerging phenotypic features of an ultrarare CDG subtype","volume":"12","author":"Kamarus Jaman N","year":"2021","unstructured":"Kamarus Jaman N, Rehsi P, Henderson RH, L\u00f6bel U, Mankad K, Grunewald S. SRD5A3-CDG: emerging phenotypic features of an ultrarare CDG subtype. Front Genet. 2021, 12:737094. 10.3389\/fgene.2021.737094","journal-title":"Front Genet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.177","article-title":"Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society","volume":"17","author":"Parikh S","year":"2015","unstructured":"Parikh S, Goldstein A, Koenig MK, et al.. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2015, 17:689-701. 10.1038\/gim.2014.177","journal-title":"Genet Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-309975","article-title":"Leber congenital amaurosis\/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions","volume":"101","author":"Kumaran N","year":"2017","unstructured":"Kumaran N, Moore AT, Weleber RG, Michaelides M. Leber congenital amaurosis\/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions. Br J Ophthalmol. 2017, 101:1147-54. 10.1136\/bjophthalmol-2016-309975","journal-title":"Br J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-20","article-title":"Joubert syndrome and related disorders","volume":"5","author":"Brancati F","year":"2010","unstructured":"Brancati F, Dallapiccola B, Valente EM. Joubert syndrome and related disorders. Orphanet J Rare Dis. 2010, 5:20. 10.1186\/1750-1172-5-20","journal-title":"Orphanet J Rare Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0207-4","article-title":"29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype","volume":"9","author":"Monin ML","year":"2014","unstructured":"Monin ML, Mignot C, De Lonlay P, et al.. 29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype. Orphanet J Rare Dis. 2014, 9:207. 10.1186\/s13023-014-0207-4","journal-title":"Orphanet J Rare Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq261","article-title":"A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism","volume":"133","author":"Morava E","year":"2010","unstructured":"Morava E, Wevers RA, Cantagrel V, et al.. A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism. Brain. 2010, 133:3210-20. 10.1093\/brain\/awq261","journal-title":"Brain"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/458061-neuro-ophthalmic-presentation-of-steroid-5a-reductase-type-3-congenital-disorder-of-glycosylation-a-case-of-monozygotic-twins","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:34:18Z","timestamp":1769697258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/458061-neuro-ophthalmic-presentation-of-steroid-5a-reductase-type-3-congenital-disorder-of-glycosylation-a-case-of-monozygotic-twins"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.102557","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,29]]}}}